Pyoderma gangrenosum in the United States: incidence and prevalence estimates from a large administrative claims database
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s853
DOI: 10.25251/7wck2g70 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Arash Mostaghimi und 8 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pyoderma gangrenosum (PG) is a rare inflammatory skin disease that can begin as a small pustule and rapidly progress into a painful ulcer. Patients with PG experience substantial disease burden due to severe pain and impaired quality of life. Variability in clinical presentation, lack of clear diagnostic criteria, and frequent misidentification contribute to limited understanding of PG incidence and prevalence in the US. This study estimated PG incidence and prevalence among patients in the US using a large administrative claims database.
Methods
This non-interventional cohort study used data from Optum Clinformatics® Data Mart spanning January 1, 2016, to March 31, 2024. This database contains de-identified medical and pharmacy claims from >126 million individuals in the US. Patients with ≥365 days of continuous baseline healthcare enrollment, including any gaps ≤32 days, were included in the cohort. Patients with PG were identified by three distinct PG claims within any 365-day period after cohort entry, and those without a PG claim during the 365-day baseline period were classified as having newly diagnosed (incident) PG. Demographic and clinical characteristics were assessed among patients with incident PG and all patients with PG (prevalent group). Crude and age- and sex-adjusted incidence rates per 100,000 person-years (PY), and period prevalence estimates per 100,000 persons, were calculated.
Results
Overall, there were 1,673 and 1,942 patients in the incident and prevalent PG groups, respectively. The crude incidence rate of PG was 2.04 (95% CI, 1.95-2.14) per 100,000 PY, and crude period prevalence was 7.74 (7.40-8.09) per 100,000 persons. The adjusted incidence rate was 1.71 (1.63-1.80) per 100,000 PY, and it increased with patient age: 0.04 (0.01-0.11) for ages 1-11 years, 0.18 (0.08-0.35) for ages 12-17 years, and 2.00 (1.89, 2.10) for adults (≥18 years old). Among adults (n=1,663), the adjusted incidence rate was greater among patients aged ≥65 years (3.34, 3.11-3.60) versus 51-64 years (2.37, 2.14-2.61) or 18-50 years (0.97, 0.87-1.08), females (2.55, 2.40-2.72) compared with males (1.38, 1.26-1.51), Black or African American (4.08, 3.52-4.70) versus White (2.91, 2.73-3.11) or Asian (0.82, 0.47-1.32) patients, and in not Hispanic or Latino (2.99, 2.79-3.21) compared with Hispanic or Latino (1.56, 1.25-1.92) patients. The overall adjusted period prevalence of PG was 6.30 (6.01-6.61), and in adults it was 7.37 (7.03-7.73), per 100,000 persons. Trends in period prevalence were similar to those observed for incidence. Approximately two-thirds of adults with PG were ≥65 years old, female, and White, respectively, and over one-half were not Hispanic or Latino. Additionally, about one-third of adults had idiopathic PG, and three-quarters had history of systemic treatment. The mean Charlson Comorbidity Index was 5.1 (SD, 3.2) for adults across the incident and prevalent groups.
Conclusion
This population-level analysis provides the first estimate of PG incidence in the US and found higher PG incidence rates and period prevalence estimates among patients who were ≥65 years old, female, Black or African American, and not Hispanic or Latino. Period prevalence was slightly higher than previously reported, which may reflect differences in study design, patient populations, and PG identification criteria.
Zitieren
APA
Mostaghimi, A., Chiu, G. R., Londhe, A., Ng, C., Nili, M., Salehi, S., Bohn, R. L., Hall, C., & Dini, V. (2026). Pyoderma gangrenosum in the United States: incidence and prevalence estimates from a large administrative claims database. SKIN The Journal of Cutaneous Medicine, 10(6), s853. https://doi.org/10.25251/7wck2g70
Vancouver
Mostaghimi A, Chiu GR, Londhe A, Ng C, Nili M, Salehi S, et al. Pyoderma gangrenosum in the United States: incidence and prevalence estimates from a large administrative claims database. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s853. doi:10.25251/7wck2g70
BibTeX
@article{Mostaghimi2026,
author = {Mostaghimi, Arash and Chiu, Gretchen R. and Londhe, Ajit and Ng, Carmen and Nili, Mona and Salehi, Sahar and Bohn, Rhonda L. and Hall, Clinton and Dini, Valentina},
title = {Pyoderma gangrenosum in the United States: incidence and prevalence estimates from a large administrative claims database},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s853},
doi = {10.25251/7wck2g70}
}
EUVIMED